Whether the anti-inflammatory action of C. montagnei in this model of colonic inflammation takes place exclusively by inhibition of inflammatory mediators, such as cytokines or NO, or by inhibition of the expression of NF-κB, still requires further investigation. This evidence concerns the gene NFKB1 and inflammation.